President Trump signs a monumental executive order fast-tracking psychedelics for mental health treatment, and ibogaine is repeatedly highlighted. What is ibogaine?

REMOVING BARRIERS TO PSYCHEDELIC DRUGS AS POTENTIAL TREATMENT FOR SERIOUS MENTAL ILLNESS: Today, President Donald J. Trump ...

The numbers are the first to quantify the effect of the Trump administration’s shutdown and restarting of a program that has ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...

Breast02, led by a senior medical oncologist and researcher from the National Cancer Centre Singapore, has demonstrated a ...

MS treatments during pregnancy do not seem to increase the risk of neurodevelopmental disorders in exposed children, a study ...

Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...

Received FDA Fast Track Designation for pevifoscorvir sodium for the treatment of chronic hepatitis B virus infectionHBeAg- cohort sample size ...

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...

A client struggling with gender identity asks for conversion therapy. You know it is harmful but a court decision seems to permit it. Do you honor or refuse the client's request?